207 related articles for article (PubMed ID: 20569500)
1. Immediate determination of ACPA and rheumatoid factor--a novel point of care test for detection of anti-MCV antibodies and rheumatoid factor using a lateral-flow immunoassay.
Renger F; Bang H; Feist E; Fredenhagen G; Natusch A; Backhaus M; Burmester GR; Egerer K
Arthritis Res Ther; 2010; 12(3):R120. PubMed ID: 20569500
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of anti-modified citrullinated vimentin in rheumatoid arthritis.
Maraina CH; Nurdayana AK; Rusni D; Azwany Y
Int J Rheum Dis; 2010 Oct; 13(4):335-9. PubMed ID: 21199468
[TBL] [Abstract][Full Text] [Related]
3. The performance of a point of care test for detection of anti-mutated citrullinated vimentin and rheumatoid factor in early rheumatoid arthritis.
Rojanasantikul P; Pattrapornpisut P; Anuruckparadorn K; Katchamart W
Clin Rheumatol; 2014 Jul; 33(7):919-23. PubMed ID: 24577818
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.
Soós L; Szekanecz Z; Szabó Z; Fekete A; Zeher M; Horváth IF; Dankó K; Kapitány A; Végvári A; Sipka S; Szegedi G; Lakos G
J Rheumatol; 2007 Aug; 34(8):1658-63. PubMed ID: 17611988
[TBL] [Abstract][Full Text] [Related]
5. The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis.
Liu X; Jia R; Zhao J; Li Z
J Rheumatol; 2009 Jun; 36(6):1136-42. PubMed ID: 19447936
[TBL] [Abstract][Full Text] [Related]
6. Selected cyclic citrullinated peptides derived from the sequence of mutated and citrullinated vimentin (MCV) are targeted by different antibodies subclasses in patients with rheumatoid arthritis in Russian patients.
Derganova O; Martinez-Gamboa L; Egerer K; Bang H; Fredenhagen G; Roggenbuck D; Esaulenko I; Burmester GR; Chernykh T; Feist E
Clin Exp Rheumatol; 2014; 32(5):622-9. PubMed ID: 25189876
[TBL] [Abstract][Full Text] [Related]
7. Anti-MCV antibodies predict radiographic progression in Greek patients with very early (<3 months duration) rheumatoid arthritis.
Barouta G; Katsiari CG; Alexiou I; Liaskos C; Varna A; Bogdanos DP; Germenis AE; Sakkas LI
Clin Rheumatol; 2017 Apr; 36(4):885-894. PubMed ID: 27943044
[TBL] [Abstract][Full Text] [Related]
8. Carbamylated vimentin represents a relevant autoantigen in Latin American (Cuban) rheumatoid arthritis patients.
Martínez G; Gómez JA; Bang H; Martínez-Gamboa L; Roggenbuck D; Burmester GR; Torres B; Prada D; Feist E
Rheumatol Int; 2016 Jun; 36(6):781-91. PubMed ID: 27038800
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: an Italian multicentric study and review of the literature.
Bartoloni E; Alunno A; Bistoni O; Bizzaro N; Migliorini P; Morozzi G; Doria A; Mathieu A; Lotzniker M; Allegri F; Riccieri V; Alpini C; Gabrielli A; Tampoia M; Gerli R;
Autoimmun Rev; 2012 Sep; 11(11):815-20. PubMed ID: 22394488
[TBL] [Abstract][Full Text] [Related]
10. A comparison between IgG- and IgA-class antibodies to cyclic citrullinated peptides and to modified citrullinated vimentin in early rheumatoid arthritis and very early arthritis.
Svärd A; Kastbom A; Söderlin MK; Reckner-Olsson Å; Skogh T
J Rheumatol; 2011 Jul; 38(7):1265-72. PubMed ID: 21459947
[TBL] [Abstract][Full Text] [Related]
11. Comparison of anti-mutated citrullinated vimentin, anti-cyclic citrullinated peptides, anti-glucose-6-phosphate isomerase and anti-keratin antibodies and rheumatoid factor in the diagnosis of rheumatoid arthritis in Chinese patients.
Zhu T; Feng L
Int J Rheum Dis; 2013 Apr; 16(2):157-61. PubMed ID: 23773638
[TBL] [Abstract][Full Text] [Related]
12. The presence of anti-citrullinated protein antibodies (ACPA) and rheumatoid factor on patients with rheumatoid arthritis (RA) does not interfere with the chance of clinical remission in a follow-up of 3 years.
da Mota LM; Dos Santos Neto LL; de Carvalho JF; Pereira IA; Burlingame R; Ménard HA; Laurindo IM
Rheumatol Int; 2012 Dec; 32(12):3807-12. PubMed ID: 22187055
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis.
Dejaco C; Klotz W; Larcher H; Duftner C; Schirmer M; Herold M
Arthritis Res Ther; 2006; 8(4):R119. PubMed ID: 16859519
[TBL] [Abstract][Full Text] [Related]
14. Anti-CCP2 is an adjunct to, not a surrogate for, rheumatoid factor in the diagnosis of rheumatoid arthritis: diagnostic utility of anti-CCP2 antibodies in Egyptian patients with rheumatoid arthritis.
Abdel-Nasser AM; Mahmoud MH; El Mansoury TM; Osman AM
Scand J Rheumatol; 2008; 37(5):329-36. PubMed ID: 18666028
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
Reyes-Castillo Z; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla GE; del Toro-Arreola S; Ramírez-Dueñas MG; Ocampo-Bermudes G; Muñoz-Valle JF
Clin Exp Immunol; 2015 Nov; 182(2):119-31. PubMed ID: 26149185
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis: compared with anti-CCP and rheumatoid factor, could anti-MCV be the next biomarker in the rheumatoid arthritis classification criteria?
Zhu JN; Nie LY; Lu XY; Wu HX
Clin Chem Lab Med; 2019 Oct; 57(11):1668-1679. PubMed ID: 31141478
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of antibodies to modified citrullinated vimentin in early rheumatoid arthritis.
Sizova L
Hum Immunol; 2012 Apr; 73(4):389-92. PubMed ID: 22333689
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies to citrullinated fibrinogen compared with anti-MCV and anti-CCP2 antibodies in diagnosing rheumatoid arthritis at an early stage: data from the French ESPOIR cohort.
Nicaise-Roland P; Nogueira L; Demattei C; de Chaisemartin L; Rincheval N; Cornillet M; Grootenboer-Mignot S; Dieudé P; Dougados M; Cantagrel A; Meyer O; Serre G; Chollet-Martin S
Ann Rheum Dis; 2013 Mar; 72(3):357-62. PubMed ID: 22580581
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of antibodies against mutated citrullinated vimentin for rheumatoid arthritis.
Besada E; Nikolaisen C; Nossent H
Clin Exp Rheumatol; 2011; 29(1):85-8. PubMed ID: 21269572
[TBL] [Abstract][Full Text] [Related]
20. Relationship between rheumatoid factor isotypes and IgG anti-cyclic citrullinated peptide antibodies.
Jaskowski TD; Hill HR; Russo KL; Lakos G; Szekanecz Z; Teodorescu M
J Rheumatol; 2010 Aug; 37(8):1582-8. PubMed ID: 20516016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
